Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 218

1.

Searching cerebrovascular risk indicators for hypertensive patients: Is Framingham Stroke Risk Profile "the magic bullet"?

Semplicini A.

J Clin Hypertens (Greenwich). 2018 Feb;20(2):246-247. doi: 10.1111/jch.13176. Epub 2018 Jan 22. No abstract available.

2.

Aortic stenting in the growing sheep causes aortic endothelial dysfunction but not hypertension: Clinical implications for coarctation repair.

Maschietto N, Semplicini L, Ceolotto G, Cattelan A, Poser Dvm H, Iacopetti I, Gerardi G, De Benedictis GM, Pilla T, Bernardini D, Aresu L, Rizzo S, Basso C, Semplicini A, Milanesi O.

Congenit Heart Dis. 2017 Jan;12(1):74-83. doi: 10.1111/chd.12406. Epub 2016 Sep 7.

PMID:
27600478
3.

Cerebral White Matter Lesions as a Clinically Relevant Intermediate Target of Cerebrovascular Prevention.

Semplicini A.

J Clin Hypertens (Greenwich). 2015 Sep;17(9):699-700. doi: 10.1111/jch.12584. Epub 2015 Jun 1. No abstract available.

4.

G-Protein β3-Subunit Gene C825T Polymorphism and Cardiovascular Risk: An Updated Review.

Semplicini A, Grandi T, Sandonà C, Cattelan A, Ceolotto G.

High Blood Press Cardiovasc Prev. 2015 Sep;22(3):225-32. doi: 10.1007/s40292-015-0093-4. Epub 2015 Apr 23. Review.

PMID:
25903425
5.

NAD(+)-dependent SIRT1 deactivation has a key role on ischemia-reperfusion-induced apoptosis.

Cattelan A, Ceolotto G, Bova S, Albiero M, Kuppusamy M, De Martin S, Semplicini A, Fadini GP, de Kreutzenberg SV, Avogaro A.

Vascul Pharmacol. 2015 Jul;70:35-44. doi: 10.1016/j.vph.2015.02.004. Epub 2015 Apr 9.

PMID:
25863291
6.

An update on hypertensive emergencies and urgencies.

Muiesan ML, Salvetti M, Amadoro V, di Somma S, Perlini S, Semplicini A, Borghi C, Volpe M, Saba PS, Cameli M, Ciccone MM, Maiello M, Modesti PA, Novo S, Palmiero P, Scicchitano P, Rosei EA, Pedrinelli R; Working Group on Hypertension, Prevention, Rehabilitation of the Italian Society of Cardiology, the Societa’ Italiana dell’Ipertensione Arteriosa.

J Cardiovasc Med (Hagerstown). 2015 May;16(5):372-82. doi: 10.2459/JCM.0000000000000223. Review.

PMID:
25575271
7.

Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: the SOPHIA study.

Frau F, Zaninello R, Salvi E, Ortu MF, Braga D, Velayutham D, Argiolas G, Fresu G, Troffa C, Bulla E, Bulla P, Pitzoi S, Piras DA, Glorioso V, Chittani M, Bernini G, Bardini M, Fallo F, Malatino L, Stancanelli B, Regolisti G, Ferri C, Desideri G, Scioli GA, Galletti F, Sciacqua A, Perticone F, Degli Esposti E, Sturani A, Semplicini A, Veglio F, Mulatero P, Williams TA, Lanzani C, Hiltunen TP, Kontula K, Boerwinkle E, Turner ST, Manunta P, Barlassina C, Cusi D, Glorioso N.

Pharmacogenomics. 2014 Sep;15(13):1643-52. doi: 10.2217/pgs.14.119.

PMID:
25410890
8.

Sirtuin 1 stabilization by HuR represses TNF-α- and glucose-induced E-selectin release and endothelial cell adhesiveness in vitro: relevance to human metabolic syndrome.

Ceolotto G, De Kreutzenberg SV, Cattelan A, Fabricio AS, Squarcina E, Gion M, Semplicini A, Fadini GP, Avogaro A.

Clin Sci (Lond). 2014 Oct;127(7):449-61. doi: 10.1042/CS20130439.

PMID:
24702436
9.

Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.

Travaglino F, Russo V, De Berardinis B, Numeroso F, Catania P, Cervellin G, Nigra SG, Geraci F, Bressan MA, Guerrini S, Cavazza M, Folli C, Monzani V, Battista S, Mengozzi G, Noto P, Carpinteri G, Semplicini A, Stella F, Ingrassia S, Moscatelli P, Giuntini P, Salerno G, Cardelli P, Di Somma S.

Am J Emerg Med. 2014 Apr;32(4):334-41. doi: 10.1016/j.ajem.2013.12.045. Epub 2014 Jan 3.

PMID:
24559907
10.

Two-dimensional, M-mode and Doppler-derived echocardiographic parameters in sedated healthy growing female sheep.

Poser H, Semplicini L, De Benedictis GM, Gerardi G, Contiero B, Maschietto N, Valerio E, Milanesi O, Semplicini A, Bernardini D.

Lab Anim. 2013 Jul;47(3):194-202. doi: 10.1177/0023677213486895. Epub 2013 May 16.

PMID:
23760962
11.

Abnormal cerebral electrogenesis is associated with impaired cognitive performance in hypertensive patients.

Montagnese S, Schiff S, Realdi A, Inverso G, Pellegrini A, Iannizzi P, Manara R, Mapelli D, Amodio P, Semplicini A.

J Hum Hypertens. 2013 Jul;27(7):463-4. doi: 10.1038/jhh.2013.21. Epub 2013 Mar 21. No abstract available.

PMID:
23514845
12.

Treatment options in fibromuscular dysplasia of the renal artery: when percutaneous transluminal angioplasty is at high risk?

Pengo MF, Ragazzi R, Fittà C, Grego F, Semplicini A.

Hypertens Res. 2013 Apr;36(4):383-4. doi: 10.1038/hr.2012.193. Epub 2013 Jan 10. No abstract available.

PMID:
23303291
13.

Padova Hospitale Onlus: report of a 15-year experience in surgical and medical assistance in developing countries.

Semplicini A, Vindigni V, Giatsidis G, Chiarelli A.

Ann Plast Surg. 2013 Jul;71(1):6-9. doi: 10.1097/SAP.0b013e318244efd2.

PMID:
23241761
14.

Outcome after acute ischemic stroke (AIS) in older patients: effects of age, neurological deficit severity and blood pressure (BP) variations.

Giantin V, Semplicini A, Franchin A, Simonato M, Baccaglini K, Attanasio F, Toffanello ED, Manzato E.

Arch Gerontol Geriatr. 2011 May-Jun;52(3):e185-91. doi: 10.1016/j.archger.2010.11.002. Epub 2010 Dec 8.

PMID:
21145118
15.

Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives.

Ceolotto G, Papparella I, Bortoluzzi A, Strapazzon G, Ragazzo F, Bratti P, Fabricio AS, Squarcina E, Gion M, Palatini P, Semplicini A.

Am J Hypertens. 2011 Feb;24(2):241-6. doi: 10.1038/ajh.2010.211. Epub 2010 Oct 21.

PMID:
20966899
16.

In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study.

Di Somma S, Magrini L, Pittoni V, Marino R, Mastrantuono A, Ferri E, Ballarino P, Semplicini A, Bertazzoni G, Carpinteri G, Mulè P, Pazzaglia M, Shah K, Maisel A, Clopton P.

Crit Care. 2010;14(3):R116. doi: 10.1186/cc9067. Epub 2010 Jun 16.

17.

RGS2 expression and aldosterone: renin ratio modulate response to drug therapy in hypertensive patients.

Semplicini A, Strapazzon G, Papparella I, Sartori M, Realdi A, Macchini L, Calò LA, Ceolotto G.

J Hypertens. 2010 May;28(5):1104-8. doi: 10.1097/HJH.0b013e328339930f.

PMID:
20375904
18.

Blood pressure control has distinct effects on executive function, attention, memory and markers of cerebrovascular damage.

Semplicini A, Inverso G, Realdi A, Macchini L, Maraffon M, Puato M, Zanardo M, Tirrito C, Amodio P, Schiff S, Mapelli D, Manara R.

J Hum Hypertens. 2011 Feb;25(2):80-7. doi: 10.1038/jhh.2010.28. Epub 2010 Mar 18.

PMID:
20237503
19.

Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms.

de Kreutzenberg SV, Ceolotto G, Papparella I, Bortoluzzi A, Semplicini A, Dalla Man C, Cobelli C, Fadini GP, Avogaro A.

Diabetes. 2010 Apr;59(4):1006-15. doi: 10.2337/db09-1187. Epub 2010 Jan 12.

20.

Obsessive-Compulsive and Post Traumatic Avoidance Symptoms Influence the Response to Antihypertensive Therapy: Relevance in Uncontrolled Hypertension.

Realdi A, Favaro A, Santonastaso P, Nuti M, Parotto E, Inverso G, Leoni M, Macchini L, Vettore F, Calo L, Semplicini A.

Pharmaceuticals (Basel). 2009 Nov 16;2(3):82-93.

21.

Should travelers with hypertension adjust their medications when traveling to high altitude?

Strapazzon G, Semplicini A.

High Alt Med Biol. 2009 Fall;10(3):305; author reply 306. doi: 10.1089/ham.2009.1021. No abstract available.

PMID:
19775224
22.

High angiotensin II state without cardiac remodeling (Bartter's and Gitelman's syndromes): are angiotensin II type 2 receptors involved?

Calò LA, Montisci R, Scognamiglio R, Davis PA, Pagnin E, Schiavo S, Mormino P, Semplicini A, Palatini P, D'Angelo A, Pessina AC.

J Endocrinol Invest. 2009 Nov;32(10):832-6. doi: 10.3275/6430. Epub 2009 Jul 14.

PMID:
19605975
23.

High-altitude cerebral effects: risks and mechanisms.

Strapazzon G, Semplicini A.

Lancet Neurol. 2009 Jul;8(7):604; author reply 605. doi: 10.1016/S1474-4422(09)70159-0. No abstract available.

PMID:
19539231
24.

Fibrinogen kinetics and protein turnover in hypertension: Effects of insulin.

Kiwanuka E, Coracina A, Vettore M, Semplicini A, Zaramella M, Millioni R, Puricelli L, Baiocchi MR, Tessari P.

Nutr Metab Cardiovasc Dis. 2009 Dec;19(11):789-96. doi: 10.1016/j.numecd.2009.01.005. Epub 2009 Apr 5.

PMID:
19346115
25.

Hypertension after acute ischemic stroke in older patients: effect on neurological outcome.

Giantin V, Franchin A, Seresin C, Toffanello ED, Simonato M, Panzuto G, Manzato E, Enzi G, Semplicini A.

J Am Geriatr Soc. 2008 Oct;56(10):1971-3. doi: 10.1111/j.1532-5415.2008.01869.x. No abstract available.

PMID:
19054210
26.

Evidence based medicine or interpretation of evidence based medicine?

Semplicini A, Pengo M.

Intern Emerg Med. 2009 Apr;4(2):97-8. doi: 10.1007/s11739-008-0215-2. Epub 2008 Dec 4. No abstract available.

PMID:
19052700
27.

Angiotensin II type 1 receptor gene polymorphism predicts development of hypertension and metabolic syndrome.

Palatini P, Ceolotto G, Dorigatti F, Mos L, Santonastaso M, Bratti P, Papparella I, Pessina AC, Semplicini A.

Am J Hypertens. 2009 Feb;22(2):208-14. doi: 10.1038/ajh.2008.319. Epub 2008 Nov 20.

PMID:
19023273
28.

An abnormal gene expression of the beta-adrenergic system contributes to the pathogenesis of cardiomyopathy in cirrhotic rats.

Ceolotto G, Papparella I, Sticca A, Bova S, Cavalli M, Cargnelli G, Semplicini A, Gatta A, Angeli P.

Hepatology. 2008 Dec;48(6):1913-23. doi: 10.1002/hep.22533.

PMID:
19003918
29.

Acute mountain sickness in a subject with metabolic syndrome at high altitude.

Strapazzon G, Cogo A, Semplicini A.

High Alt Med Biol. 2008 Fall;9(3):245-8. doi: 10.1089/ham.2007.1075.

PMID:
18800964
30.
31.

Antihypertensive treatment and cognitive function: another tempest in a P pot?

Semplicini A, Inverso G.

J Hypertens. 2008 Aug;26(8):1551-2. doi: 10.1097/HJH.0b013e328306a72d. No abstract available.

PMID:
18622230
32.

Nifedipine versus carvedilol in the treatment of de novo arterial hypertension after liver transplantation: results of a controlled clinical trial.

Galioto A, Semplicini A, Zanus G, Fasolato S, Sticca A, Boccagni P, Frigo AC, Cillo U, Gatta A, Angeli P.

Liver Transpl. 2008 Jul;14(7):1020-8. doi: 10.1002/lt.21442.

33.

Intravenous thrombolysis in the emergency department for the treatment of acute ischaemic stroke.

Semplicini A, Benetton V, Macchini L, Realdi A, Manara R, Carollo C, Parotto E, Mascagna V, Leoni M, Calò LA, Pessina AC, Tosato F.

Emerg Med J. 2008 Jul;25(7):403-6. doi: 10.1136/emj.2007.053033.

34.

Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes.

Calò LA, Pagnin E, Ceolotto G, Davis PA, Schiavo S, Papparella I, Semplicini A, Pessina AC.

J Hypertens. 2008 May;26(5):938-45. doi: 10.1097/HJH.0b013e3282f60d98.

PMID:
18398336
35.

A pheochromocytoma with normal clonidine-suppression test: how difficult the biochemical diagnosis?

Sartori M, Cosenzi A, Bernobich E, Calo LA, Bellini G, Semplicini A.

Intern Emerg Med. 2008 Mar;3(1):61-4. doi: 10.1007/s11739-008-0093-7. Epub 2008 Feb 9. No abstract available.

PMID:
18264666
36.

RGS2 C1114G polymorphism and body weight gain in hypertensive patients.

Sartori M, Ceolotto G, Dorigatti F, Mos L, Santonastaso M, Bratti P, Papparella I, Semplicini A, Palatini P; HARVEST Group.

Metabolism. 2008 Mar;57(3):421-7. doi: 10.1016/j.metabol.2007.10.021.

PMID:
18249218
37.

Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.

Toni D, Lorenzano S, Agnelli G, Guidetti D, Orlandi G, Semplicini A, Toso V, Caso V, Malferrari G, Fanucchi S, Bartolomei L, Prencipe M.

Cerebrovasc Dis. 2008;25(1-2):129-35. Epub 2007 Dec 11.

PMID:
18073466
38.

Linking inflammation and hypertension in humans: studies in Bartter's/Gitelman's syndrome patients.

Caló LA, Davis PA, Pagnin E, Schiavo S, Semplicini A, Pessina AC.

J Hum Hypertens. 2008 Mar;22(3):223-5. Epub 2007 Nov 29. No abstract available.

PMID:
18046435
39.

Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism.

Ceolotto G, Gallo A, Papparella I, Franco L, Murphy E, Iori E, Pagnin E, Fadini GP, Albiero M, Semplicini A, Avogaro A.

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2627-33. Epub 2007 Oct 4.

40.

Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.

Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Montemurro D, Palumbo G, Rizzoni D, Rossi E, Semplicini A, Agabiti-Rosei E, Pessina AC, Mantero F; PAPY Study Investigators.

J Hypertens. 2007 Jul;25(7):1433-42.

PMID:
17563566
41.

Urinary albumin excretion, endothelial dysfunction and cardiovascular risk: study in Bartter's/Gitelman's syndromes and relevance for hypertension.

Calò LA, Davis PA, Palatini P, Semplicini A, Pessina AC.

J Hum Hypertens. 2007 Nov;21(11):904-6. Epub 2007 May 10. No abstract available.

PMID:
17495949
42.

Usefulness and safety of early blood pressure lowering after ischemic stroke still unproven.

Semplicini A.

Am J Hypertens. 2007 Mar;20(3):278. No abstract available.

PMID:
17324739
43.

Autonomic nervous system function in chronic hypotension associated with Bartter and Gitelman syndromes.

Sartori M, Parotto E, Bonso E, Semplicini A, Palatini P, Pessina AC, Calò LA.

Am J Kidney Dis. 2007 Feb;49(2):330-5.

PMID:
17261437
44.

A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.

Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F; PAPY Study Investigators.

J Am Coll Cardiol. 2006 Dec 5;48(11):2293-300. Epub 2006 Nov 13.

45.

Vitamin C prevents zidovudine-induced NAD(P)H oxidase activation and hypertension in the rat.

Papparella I, Ceolotto G, Berto L, Cavalli M, Bova S, Cargnelli G, Ruga E, Milanesi O, Franco L, Mazzoni M, Petrelli L, Nussdorfer GG, Semplicini A.

Cardiovasc Res. 2007 Jan 15;73(2):432-8. Epub 2006 Oct 20.

PMID:
17123493
46.

Insulin generates free radicals in human fibroblasts ex vivo by a protein kinase C-dependent mechanism, which is inhibited by pravastatin.

Ceolotto G, Papparella I, Lenzini L, Sartori M, Mazzoni M, Iori E, Franco L, Gallo A, de Kreutzenberg SV, Tiengo A, Pessina AC, Avogaro A, Semplicini A.

Free Radic Biol Med. 2006 Aug 1;41(3):473-83. Epub 2006 Apr 30.

PMID:
16843828
47.

Problems related to short-term antihypertensive therapy in acute ischemic stroke.

Semplicini A, Benetton V, Mascagna V, Macchini L, Realdi A, Sartori M, Calò L.

Clin Exp Hypertens. 2006 Apr-May;28(3-4):327-34. Review.

PMID:
16833042
48.

Blood pressure in acute ischemic stroke and mortality: a study with noninvasive blood pressure monitoring.

Sartori M, Benetton V, Carraro AM, Calò LA, Macchini L, Giantin V, Tosato F, Pessina AC, Semplicini A.

Blood Press Monit. 2006 Aug;11(4):199-205.

PMID:
16810030
49.

Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II.

Semplicini A, Lenzini L, Sartori M, Papparella I, Calò LA, Pagnin E, Strapazzon G, Benna C, Costa R, Avogaro A, Ceolotto G, Pessina AC.

J Hypertens. 2006 Jun;24(6):1115-24.

PMID:
16685212
50.

The search for a link between inflammation and hypertension--contribution from Bartter's/Gitelman's syndromes.

Pagnin E, Davis PA, Semplicini A, Calò LA.

Nephrol Dial Transplant. 2006 Aug;21(8):2340-2. Epub 2006 Apr 12. No abstract available.

PMID:
16611677

Supplemental Content

Loading ...
Support Center